Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.

作者: Yongping Crawford , Napoleone Ferrara , None

DOI: 10.1016/J.TIPS.2009.09.004

关键词:

摘要: Identification and characterization of VEGF as an important regulator angiogenesis, FDA approval the first anti-angiogenic drugs, has enabled significant advances in therapy cancer neovascular age-related macular degeneration. However, similar to other therapies, inherent/acquired resistance drugs may occur patients, leading disease recurrence. Recent studies several experimental models suggest that tumor non-tumor (stromal) cell types be involved reduced responsiveness treatments. The present review examines role tumor- well stromal cell-derived pathways growth refractoriness anti-VEGF therapies.

参考文章(101)
M. Graziella Persico, Placenta Growth Factor Birkhäuser, Boston, MA. pp. 301- 314 ,(2001) , 10.1007/978-1-4612-0213-4_16
Jennifer LeCouter, Joe Kowalski, Jessica Foster, Phil Hass, Zemin Zhang, Lisa Dillard-Telm, Gretchen Frantz, Linda Rangell, Leo DeGuzman, Gilbert-Andre Keller, Franklin Peale, Austin Gurney, Kenneth J. Hillan, Napoleone Ferrara, Identification of an angiogenic mitogen selective for endocrine gland endothelium Nature. ,vol. 412, pp. 877- 884 ,(2001) , 10.1038/35091000
John E Park, Helen H Chen, Jane Winer, Keith A Houck, Napoleone Ferrara, None, Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Journal of Biological Chemistry. ,vol. 269, pp. 25646- 25654 ,(1994) , 10.1016/S0021-9258(18)47298-5
David J. McConkey, Corazon D. Bucana, Wenbiao Liu, Michael R. Wilson, Darren W. Davis, Raymond M. Shaheen, Lee M. Ellis, Brian K. Zebrowski, Gerald McMahon, Antiangiogenic Therapy Targeting the Tyrosine Kinase Receptor for Vascular Endothelial Growth Factor Receptor Inhibits the Growth of Colon Cancer Liver Metastasis and Induces Tumor and Endothelial Cell Apoptosis Cancer Research. ,vol. 59, pp. 5412- 5416 ,(1999)
David J. McConkey, Daniel J. Hicklin, Darren W. Davis, Keiji Inoue, Colin P.N. Dinney, Robert Radinsky, Takashi Karashima, Joel W. Slaton, Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel Clinical Cancer Research. ,vol. 6, pp. 2635- 2643 ,(2000)
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
John M.L. Ebos, Christina R. Lee, William Cruz-Munoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel, Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis Cancer Cell. ,vol. 15, pp. 232- 239 ,(2009) , 10.1016/J.CCR.2009.01.021
Kristy Red-Horse, Yongping Crawford, Farbod Shojaei, Napoleone Ferrara, Endothelium-Microenvironment Interactions in the Developing Embryo and in the Adult Developmental Cell. ,vol. 12, pp. 181- 194 ,(2007) , 10.1016/J.DEVCEL.2007.01.013
Terhi Karpanen, Caroline A. Heckman, Salla Keskitalo, Michael Jeltsch, Hanna Ollila, Gera Neufeld, Luca Tamagnone, Kari Alitalo, Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. The FASEB Journal. ,vol. 20, pp. 1462- 1472 ,(2006) , 10.1096/FJ.05-5646COM